Jennifer L. Kennemur

Jennifer L. Kennemur

Auto-generated profile, based on publicly available information

Jennifer L. Kennemur

Division of Chemistry and Chemical Engineering

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2018 in Science
Verified
Journal Article
Closed access
PDF file
NTNobuya Tsuji
Nobuya Tsuji
JKJennifer L. Kennemur
Jennifer L. Kennemur
TBThomas Buyck
Thomas Buyck
SLSunggi Lee
Sunggi Lee
SPSébastien Prévost
Sébastien Prévost
BLBenjamin List
Benjamin List
Attacking olefins with chiral acids: A little acid can accelerate a wide range of chemical reactions. The advent of chiral phosphoric acid derivatives has been useful for biasing these reactions toward just one of two mirror-image products. For the most part, though, these chiral catalysts have interacted with basic sites such as carbonyl groups. Tsuji et al. now extend asymmetric acid catalysis to simple carbon-carbon double bonds. Their custom imidodiphosphate forms a pocket that orients olefins to achieve mainly intramolecular alkoxylation on just one face after protonation. Science , this issue p. 1501

22 July 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JKJennifer L. Kennemur
Jennifer L. Kennemur
YLYueming Long
Yueming Long
CKCatherine J. Ko
Catherine J. Ko
ADAnuvab Das
Anuvab Das
FAFrances H. Arnold
Frances H. Arnold

6 May 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
JKJennifer L. Kennemur
Jennifer L. Kennemur
YLYueming Long
Yueming Long
CKCatherine J. Ko
Catherine J. Ko
ADAnuvab Das
Anuvab Das
FAFrances H. Arnold
Frances H. Arnold
Azaspiro[2.y]alkanes are increasingly valuable scaffolds in pharmaceutical drug discovery; however, an asymmetric catalytic method for their synthesis remains unknown. Here, we present a stereodivergent carbene transferase platform for the cyclo-propanation of unsaturated exocyclic N-heterocycles to provide structurally-diverse and pharmaceutically-relevant azaspi-ro[2.y]alkanes in high yield (21–>99% yield) and excellent diastereo- and enantioselectivity (dr from 52.5:47.5 to >99.5:0.5; er from 51:49 to >99.5:0.5). These engineered protoglobin-based enzymes operate on gram scale, with no organic co-solvent, at substrate concentrations up to 150 mM (25 g/L) using lyophilized E. coli lysate as the catalyst. This platform represents a practical, scalable, and stereodivergent biocatalytic synthesis of azaspiro[2.y]alkanes using low-cost engineered protoglobins and their native iron-heme cofactors.